Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Lineage Commitment01:21

Lineage Commitment

4.0K
Commitment is the  process whereby stem cells:
4.0K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.7K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.7K
Development of the Lymphatic System01:15

Development of the Lymphatic System

1.9K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
1.9K
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

2.8K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
2.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Aneuploidy selects for the acquisition of driver genes in breast cancer.

Nature·2026
Same author

Lymphovenous Anastomosis for Treatment of Breast Lymphedema Following Delayed Autologous Reconstruction: A Case Report.

Microsurgery·2026
Same author

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same author

Langerhans cell control of early-life dermal lymphatic development shapes adult immunity.

Science immunology·2026
Same author

Neutrophil-derived itaconate facilitates tiered pulmonary inflammation via Kdm5b-associated epigenetic remodeling in alveolar macrophages.

Cell reports·2026
Same author

Critical role of keratinocytes and protease-activated receptor 2 in secondary lymphedema development.

Clinical and translational medicine·2026

関連する実験動画

Updated: Jan 4, 2026

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin
09:10

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin

Published on: December 16, 2013

6.4K

幹細胞によるリンパ系リモデリング 組織再生の調整

Shiri Gur-Cohen1, Hanseul Yang1, Sanjeethan C Baksh1

  • 1Howard Hughes Medical Institute, Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, The Rockefeller University, New York, NY 10065, USA.

Science (New York, N.Y.)
|November 2, 2019
PubMed
まとめ
この要約は機械生成です。

リンパ毛細血管は幹細胞 (SC) の重要なニッチ成分です. SCsのセクレトームスイッチはリンパの行動を制御し,組織再生と毛皮のサイクルに影響します.

さらに関連する動画

Basement Membrane Matrix Encapsulated Cell Aggregation for Investigating Murine Spleen Tissue Formation
07:30

Basement Membrane Matrix Encapsulated Cell Aggregation for Investigating Murine Spleen Tissue Formation

Published on: June 28, 2024

1.8K
Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
12:47

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

19.3K

関連する実験動画

Last Updated: Jan 4, 2026

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin
09:10

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin

Published on: December 16, 2013

6.4K
Basement Membrane Matrix Encapsulated Cell Aggregation for Investigating Murine Spleen Tissue Formation
07:30

Basement Membrane Matrix Encapsulated Cell Aggregation for Investigating Murine Spleen Tissue Formation

Published on: June 28, 2024

1.8K
Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
12:47

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

19.3K

科学分野:

  • 幹細胞生物学
  • 組織再生
  • 血管生物学

背景:

  • 幹細胞 (SCs) は,専門的な微小環境 (ニッチ) に存在する組織ホメオスタシスと修復に不可欠です.
  • SCニッチが組織の成長に 果たす複雑な役割は まだ解明されていません
  • リンパ毛細血管は,重要なSCニッチ成分として広く認識されていません.

研究 の 目的:

  • 幹細胞ニッチの重要な構成要素としてリンパ毛細血管の役割を特定し,特徴づけること.
  • 組織再生中の毛胞幹細胞とリンパ毛細血管のダイナミックな相互作用を調査する.
  • 幹細胞がリンパ系を制御する 分子機構を解明する

主な方法:

  • マウスモデルを使って 幹細胞とニッチの相互作用を研究した
  • 髪の毛の幹細胞の分泌を研究した
  • 幹細胞の信号に反応する リンパ毛細血管の行動を分析した
  • リンパ管の乱れと分泌体の乱れが毛皮の循環と組織再生に与える影響を調べました.

主要な成果:

  • リンパ系毛細血管が 毛皮幹細胞の内蔵部分として特定された.
  • 幹細胞のセクレトームスイッチが発見され,静止状態のSCはリンパドレナージを促進するためにアンジオポエチン型のタンパク質7 (Angptl7) を発現し,活性化されたSCは一時的なリンパ解離のためにアンジオポエチン型のタンパク質4 (Angptl4) にスイッチする.
  • リンパ毛細血管や幹細胞の分泌の乱れが早熟な毛の葉の循環と非同期的な組織再生につながることを示した.

結論:

  • リンパ毛細血管は組織再生を動的に制御する 幹細胞の重要なニッチ成分です
  • 幹細胞のセクレトームは,特定のアンジオポエチンを通して,リンパの行動を制御し,組織修復プロセスに影響を与えます.
  • これらのSC-リンパ相互作用を理解することで,効果的な組織再生のための幹細胞活動の調整に関する洞察が得られます.